Otero Jose Manuel 4
4 · Lexeo Therapeutics, Inc. · Filed Aug 20, 2025
Insider Transaction Report
Form 4
Otero Jose Manuel
Chief Operating Officer
Transactions
- Sale
Common Stock
2025-08-18$4.67/sh−2,848$13,294→ 60,372 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 49,687 RSUs.